Literature DB >> 26859595

Psychometric properties of the Czech version of the Beck Anxiety Inventory - comparison between diagnostic groups.

Dana Kamaradova1, Jan Prasko1, Klara Latalova1, Lucie Panackova2, Jan Svancara2, Ales Grambal1, Zuzana Sigmundova1, Marie Ociskova1, Vratislav Bares1, Snezana Cakirpaloglu1, Daniela Jelenova1, Petra Kasalova1, Andrea Kovacsova1, Kristyna Vrbova1.   

Abstract

OBJECTIVE: Beck anxiety inventory (BAI) is widely used self-rating questionnaire evaluating the severity of anxiety symptoms. The aim of our study was to confirm validity and reliability of Czech version of BAI, identify cut-off points and prove sensitivity to measure improvement after therapy.
METHODS: The patients selected for the study were treated in the department of psychiatry, University Hospital Olomouc between January 2008 and 2014. Patients meeting criteria for anxiety, or depressive disorder were involved.
RESULTS: 789 patients and 284 healthy controls agreed to participate in the study. Czech version of Beck anxiety inventory proved high internal consistency (α=0.92) and good test-retest reliability over one week (BAI seems to be independent of other used scales - Beck depression inventory and the Clinical Global Impression. BAI is also sensitive to measure change after therapy.
CONCLUSION: Czech version of BAI was found to have enough internal stability and test-retest reliability same as the original version. It may also be useful to detect improvement after therapy.

Entities:  

Year:  2015        PMID: 26859595

Source DB:  PubMed          Journal:  Neuro Endocrinol Lett        ISSN: 0172-780X            Impact factor:   0.765


  9 in total

1.  Quality of life in borderline patients comorbid with anxiety spectrum disorders - a cross-sectional study.

Authors:  Ales Grambal; Jan Prasko; Dana Kamaradova; Klara Latalova; Michaela Holubova; Zuzana Sedláčková; Radovan Hruby
Journal:  Patient Prefer Adherence       Date:  2016-08-01       Impact factor: 2.711

2.  Personality features, dissociation, self-stigma, hope, and the complex treatment of depressive disorder.

Authors:  Jan Prasko; Marie Ociskova; Ales Grambal; Zuzana Sigmundova; Petra Kasalova; Marketa Marackova; Michaela Holubova; Kristyna Vrbova; Klara Latalova; Milos Slepecky
Journal:  Neuropsychiatr Dis Treat       Date:  2016-10-07       Impact factor: 2.570

3.  Comorbidity of schizophrenia and social phobia - impact on quality of life, hope, and personality traits: a cross sectional study.

Authors:  Kristyna Vrbova; Jan Prasko; Marie Ociskova; Michaela Holubova
Journal:  Neuropsychiatr Dis Treat       Date:  2017-08-03       Impact factor: 2.570

4.  Impact of dissociation on treatment of depressive and anxiety spectrum disorders with and without personality disorders.

Authors:  Jan Prasko; Ales Grambal; Petra Kasalova; Dana Kamardova; Marie Ociskova; Michaela Holubova; Kristyna Vrbova; Zuzana Sigmundova; Klara Latalova; Milos Slepecky; Marta Zatkova
Journal:  Neuropsychiatr Dis Treat       Date:  2016-10-17       Impact factor: 2.570

5.  Quality of life, self-stigma, and hope in schizophrenia spectrum disorders: a cross-sectional study.

Authors:  Kristyna Vrbova; Jan Prasko; Marie Ociskova; Dana Kamaradova; Marketa Marackova; Michaela Holubova; Ales Grambal; Milos Slepecky; Klara Latalova
Journal:  Neuropsychiatr Dis Treat       Date:  2017-02-23       Impact factor: 2.570

6.  EEG correlates of induced anxiety in obsessive-compulsive patients: comparison of autobiographical and general anxiety scenarios.

Authors:  Dana Kamaradova; Martin Brunovsky; Jan Prasko; Jiri Horacek; Miroslav Hajda; Ales Grambal; Klara Latalova
Journal:  Neuropsychiatr Dis Treat       Date:  2018-08-27       Impact factor: 2.570

7.  Self-Stigma and Treatment Effectiveness in Patients with SSRI Non-Responsive Obsessive-Compulsive Disorder.

Authors:  Marie Ociskova; Jan Prasko; Jakub Vanek; Michaela Holubova; Frantisek Hodny; Klara Latalova; Krystof Kantor; Vlastimil Nesnidal
Journal:  Psychol Res Behav Manag       Date:  2021-02-05

8.  Psychological factors and treatment effectiveness in resistant anxiety disorders in highly comorbid inpatients.

Authors:  Marie Ociskova; Jan Prasko; Klara Latalova; Dana Kamaradova; Ales Grambal
Journal:  Neuropsychiatr Dis Treat       Date:  2016-06-24       Impact factor: 2.570

9.  Self-stigma and treatment effectiveness in patients with anxiety disorders - a mediation analysis.

Authors:  Marie Ociskova; Jan Prasko; Kristyna Vrbova; Petra Kasalova; Michaela Holubova; Ales Grambal; Klara Machu
Journal:  Neuropsychiatr Dis Treat       Date:  2018-01-26       Impact factor: 2.570

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.